University of València Agri-food Industry Scientific and Technological Offer Agri-food Industry Scientific and Technological Offer Logo del portal

Research Group on Stereoselective Synthesis of Bioactive Natural Product Analogues - SEAPNB

Description

The fundamental objective of the group is to produce new types of molecules with pharmacological activity and whose structure is based on that of known natural products, which are also bioactive. Of the many types of pharmacological activities described, the group's main focus is on cytotoxic, anti-angiogenic and telomerase inhibitory activities, because of the strong influence these activities exhibit on cell proliferation processes. This gives them potential interest in anti-cancer therapeutics. Another type of pharmacological action that will also be investigated is antimalarial activity.

The group was formed some years ago on the general line of synthesis of bioactive natural products. One of its members has been collaborating for years with another group at the Universitat Jaume I in Castellón, with which it has joint research projects. At the same time, the group collaborates with external groups to carry out and determine the biological activities of the aforementioned types.

One of these groups, led by Doctors Isabel Fernández and Fernando Díaz, carries out its scientific activity in Madrid at the Centro de Investigaciones Biológicas (CIB), an entity included within the CSIC. The topics currently being addressed concern the stereoselective synthesis and biological evaluation of non-natural analogues of two bioactive natural products, combretastatin A4 and colchicine. Both show a strong inhibitory effect on cell proliferation, which makes them products of application in anticancer therapy. The aim is to create non-natural analogues of these compounds with improved pharmacological properties.

The other group is a unit within the multinational pharmaceutical company GlaxoSmithKlyne and is involved in malaria research. Our group has signed an agreement with this company that allows for the evaluation, both in vitro and in vivo, of the antimalarial properties of synthesised compounds. This is of particular importance as the evaluation of bioactive products on live animals is particularly costly and not normally possible in academic facilities.

Goals CT
  • Synthesis of analogues of biologically active compounds. Evaluation of antiangiogenic, antimitotic and telomerase inhibitory properties.
Research lines

Stereoselective synthesis of bioactive natural product analogues

El objetivo del grupo es fabricar nuevas moléculas con actividad farmacológica y con estructura basada en la de productos naturales bioactivos. Interesan principalmente las actividades citotóxicas, antiangiogénicas y de inhibición de la telomerasa, que confieren interés en la terapéutica anticáncer.

Management
  • VENTURA MARCO, MANUEL
  • PDI Jubil./Sit.Especiales-Titular d'Universitat
View details
Members
  • CUÑAT ROMERO, ANA CARMEN
  • PDI-Catedratic/a d'Universitat
View details
  • SANZ CERVERA, JUAN FRANCISCO
  • PDI-Catedratic/a d'Universitat
View details
Work team
  • BLASCO CABAÑAS, VICTOR
  • Alumn.-Servei de Formacio Permanent
View details
Non-UV research staff

Partner

  • Fernando Díaz Pereira - Consejo Superior de Investigaciones Científicas (Madrid)  
Scientific production by UV researcher
  • CUÑAT ROMERO, ANA CARMEN
    PDI-Catedratic/a d'Universitat
    Expandir
Associated structure
Contact group details
Research Group on Stereo-selective Synthesis of Analogues of Bioactive Natural Products (SEAPNB)

Burjassot/Paterna Campus

C/ Dr. Moliner, 50

46100 Burjassot (Valencia)

+34 963 544 337

Geolocation

www.uv.es/marcoj

alberto.marco@uv.es

Contact people
  • VENTURA MARCO, MANUEL
  • PDI Jubil./Sit.Especiales-Titular d'Universitat
View details